Your browser doesn't support javascript.
loading
Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination.
Sisteré-Oró, Marta; Wortmann, Diana D J; Andrade, Naína; Aguilar, Andres; Mayo de Las Casas, Clara; Casabal, Florencia Garcia; Torres, Susana; Bona Salinas, Eduardo; Raventos Soler, Laura; Arcas, Andrea; Esparre, Carlos; Garcia, Beatriz; Valarezo, Joselyn; Rosell, Rafael; Güerri-Fernandez, Roberto; Gonzalez-Cao, Maria; Meyerhans, Andreas.
  • Sisteré-Oró M; Infection Biology Laboratory, Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Wortmann DDJ; Infection Biology Laboratory, Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Andrade N; Infection Biology Laboratory, Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Aguilar A; Instituto Oncologico Dr Rosell, Hospital Quiron-Dexeus Barcelona, Barcelona, Spain.
  • Mayo de Las Casas C; Instituto Oncologico Dr Rosell, Hospital Quiron-Dexeus Barcelona, Barcelona, Spain.
  • Casabal FG; Laboratorio Oncología, Hospital Universitario Dexeus, Pangaea Oncology Lab, Barcelona, Spain.
  • Torres S; Instituto Oncologico Dr Rosell, Hospital Quiron-Dexeus Barcelona, Barcelona, Spain.
  • Bona Salinas E; Instituto Oncologico Dr Rosell, Hospital Quiron-Dexeus Barcelona, Barcelona, Spain.
  • Raventos Soler L; Instituto Oncologico Dr Rosell, Hospital Quiron-Dexeus Barcelona, Barcelona, Spain.
  • Arcas A; Instituto Oncologico Dr Rosell, Hospital Quiron-Dexeus Barcelona, Barcelona, Spain.
  • Esparre C; Instituto Oncologico Dr Rosell, Hospital Quiron-Dexeus Barcelona, Barcelona, Spain.
  • Garcia B; Instituto Oncologico Dr Rosell, Hospital Quiron-Dexeus Barcelona, Barcelona, Spain.
  • Valarezo J; Instituto Oncologico Dr Rosell, Hospital Quiron-Dexeus Barcelona, Barcelona, Spain.
  • Rosell R; Laboratorio Oncología, Hospital Universitario Dexeus, Pangaea Oncology Lab, Barcelona, Spain.
  • Güerri-Fernandez R; Instituto Oncologico Dr Rosell, Hospital Quiron-Dexeus Barcelona, Barcelona, Spain.
  • Gonzalez-Cao M; Laboratorio Oncología, Hospital Universitario Dexeus, Pangaea Oncology Lab, Barcelona, Spain.
  • Meyerhans A; Instituto Oncologico Dr Rosell, Hospital Quiron-Dexeus Barcelona, Barcelona, Spain.
Front Immunol ; 13: 908108, 2022.
Article en En | MEDLINE | ID: mdl-35911701

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas Virales / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas Virales / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article